Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

ValiRx (VAL) Share News

IN BRIEF: ValiRx signs research sharing deal with Dundee University

12th Feb 2024 11:42

ValiRx PLC - Nuneaton, England-based life sciences company focused on early-stage cancer therapeutics - Signs agreement with Dundee University's drug discovery unit to access research concerning novel therapeutic candidates. The agreement will be active for a period of five years, in which ValiRx may review research projects from the unit in areas aligned with the company's focus on cancer therapeutics. Read More

TRADING UPDATES: ValiRx receives shareholder request for board change

9th Feb 2024 20:24

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News: Read More

UK shareholder meetings calendar - next 7 days

28th Dec 2023 15:56

IN BRIEF: ValiRx raises GBP192,200, part of wider GBP1.8 million raise

19th Dec 2023 20:46

ValiRx PLC - life science company based near Birmingham, England, which is focused on early-stage cancer therapeutics and women's health - Says 3.2 million new shares have been subscribed for at 6 pence per share via a retail offer, raising GBP192,244. Also issues 499,998 new shares via a subscription. In total, raises GBP1.8 million via placing, subscription and retail offer of 30.0 million new shares. Read More

TRADING UPDATES: Good Energy says ZapMap expands into mainland Europe

13th Dec 2023 21:14

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More

ValiRx says ValiSeek inks deal to licence VAL401 drug with Ambrose

5th Dec 2023 11:17

(Alliance News) - ValiRx PLC on Tuesday said that ValiSeek Ltd it has entered a deal to licence VAL401 with Ambrose Healthcare Ltd, a private UK specialist pharmaceutical company. Read More

AIM WINNERS & LOSERS: tinyBuild warns on revenue; ValiRx rises

5th Dec 2023 10:59

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Tuesday. Read More

ValiRx signs deal to evaluate StingRay Bio drug candidates

10th Nov 2023 11:49

(Alliance News) - ValiRx PLC on Friday said it has signed a deal with StingRay Bio Ltd to investigate a series of drug candidates. Read More

ValiRx sees no reason for shares jump; notes TheoremRx mulls merger

6th Oct 2023 11:35

(Alliance News) - ValiRx PLC on Friday said it had no unpublished information that was sensitive to its share price, as it rose significantly. Read More

ValiRx interim loss widens as costs increase; hails Inaphaea progress

24th Aug 2023 11:06

(Alliance News) - ValiRx PLC on Thursday reported an increased half-year loss amid higher costs, as it continued to focus on building its science-focused portfolio. Read More

ValiRx signs collaborative services agreement with Agility

14th Aug 2023 08:52

(Alliance News) - ValiRx PLC on Monday said its wholly-owned subsidiary, Inaphaea BioLabs Ltd, has entered into a collaborative services agreement with Agility Life Sciences Ltd. Read More

IN BRIEF: ValiRx subsidiary secures contract with UK biotech firm

19th Jul 2023 09:39

ValiRx PLC - Essex, England-based life science company focused on early-stage cancer therapeutics and women's health - Says subsidiary Inaphea BioLabs Ltd will partner with an unnamed UK-based biotechnology company on a phenotypic assay to investigate anti-cancer properties using patient-derived cells from Inaphea's biobank. Adds Inaphea has started internal studies on ValiRx assets s VAL301 and Cytolytix CLX001. "This defined work programme involves a multi-stage project and is expected to complete at the end of September 2023," ValiRx says. Read More

TRADING UPDATES: All Things Considered raises funds to buy Sandbag

28th Jun 2023 20:25

(Alliance News) - The following is a round-up of updates by London-listed companies, issued Wednesday and not separately reported by Alliance News: Read More

UK shareholder meetings calendar - next 7 days

21st Jun 2023 15:43

IN BRIEF: ValiRx subsidiary to supply cell-based assays to OncoBone

19th Jun 2023 11:51

ValiRx PLC - Essex, England-based life science company focused on early-stage cancer therapeutics and women's health - Says subsidiary Inaphaea Biolabs Ltd enters agreement with OncoBone Ltd. Says OncoBone clients will be able to access Inaphaea services. Notes Inaphaea is now confirmed as a cell-based assay supplier to OncoBone. Adds Inaphaea's services are now listed on scientist.com, a database website used by biotechnology and pharmaceutical companies. Read More

FTSE 100 Latest

Value8,809.74

Change53.53